ATOMOXETINE

Clinical Indication

Attention deficit hyperactivity disorder (ADHD)

Comments

Adults
Full SCA

Children and adolescents
Full SCA

 

Date of classification

January 2009

Orange

Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.